Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

701.1500 5.60 (0.81%)

NSE May 22, 2025 09:57 AM

58.14% Fall from 52W High

Volume: 110.5K

Strides Pharma Science Ltd.

24 Feb 2023

701.15

0.81%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides flagship facility in Bangalore receives USFDA inspection closure

More from Strides Pharma Science Ltd.

Recommended

Market opens lower, ONGC's Q4FY25 net profit declines 27.6% YoY to Rs 7,322.8 crore

Trendlyne Marketwatch | 22 May 2025, 09:45AM

From grid to gains: Transformer makers electrify the market

The Baseline | 21 May 2025, 10:23AM

Earnings Call Transcript - Q1FY21 for Strides Pharma Science